Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants

Waldemar A. Carlo, Ann R. Stark, Linda L. Wright, Jon E. Tyson, Lu Ann Papile, Seetha Shankaran, Edward F. Donovan, William Oh, Charles R Bauer, Shampa Saha, W. Kenneth Poole, Barbara Stoll

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Objective: To determine whether minimal ventilation decreases death or bronchopulmonary dysplasia (BPD). Study design: Infants with birth weight 501 g to 1000 g and mechanically ventilated before 12 hours were randomly assigned to minimal ventilation (partial pressure of carbon dioxide [PCO2] target >52 mm Hg) or routine ventilation (PCO2 target <48 mm Hg) and a tapered dexamethasone course or saline placebo for 10 days, using a 2 × 2 factorial design. The primary outcome was death or BPD at 36 weeks' postmenstrual age. Results: After enrollment of 220 patients, the trial was halted because of unanticipated nonrespiratory adverse events related to dexamethasone therapy. The relative risk for death or BPD at 36 weeks in the minimal versus routine ventilation groups was 0.93 (95% CI, 0.77-1.12; P = .43). Ventilator support at 36 weeks was 1% in the minimal versus 16% in the routine group (P < .01). Major morbidities and long-term outcome were comparable in both treatment groups. Conclusions: With the sample size studied, minimal ventilation did not reduce the incidence of death or BPD. The reduced ventilator support at 36 weeks in the minimal ventilation group warrants further study of this intervention.

Original languageEnglish
Pages (from-to)370-375
Number of pages6
JournalJournal of Pediatrics
Volume141
Issue number3
DOIs
StatePublished - Sep 1 2002

Fingerprint

Extremely Low Birth Weight Infant
Bronchopulmonary Dysplasia
Ventilation
Mechanical Ventilators
Dexamethasone
Partial Pressure
Birth Weight
Carbon Dioxide
Sample Size
Placebos
Morbidity
Incidence
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Carlo, W. A., Stark, A. R., Wright, L. L., Tyson, J. E., Papile, L. A., Shankaran, S., ... Stoll, B. (2002). Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. Journal of Pediatrics, 141(3), 370-375. https://doi.org/10.1067/mpd.2002.127507

Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. / Carlo, Waldemar A.; Stark, Ann R.; Wright, Linda L.; Tyson, Jon E.; Papile, Lu Ann; Shankaran, Seetha; Donovan, Edward F.; Oh, William; Bauer, Charles R; Saha, Shampa; Poole, W. Kenneth; Stoll, Barbara.

In: Journal of Pediatrics, Vol. 141, No. 3, 01.09.2002, p. 370-375.

Research output: Contribution to journalArticle

Carlo, WA, Stark, AR, Wright, LL, Tyson, JE, Papile, LA, Shankaran, S, Donovan, EF, Oh, W, Bauer, CR, Saha, S, Poole, WK & Stoll, B 2002, 'Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants', Journal of Pediatrics, vol. 141, no. 3, pp. 370-375. https://doi.org/10.1067/mpd.2002.127507
Carlo, Waldemar A. ; Stark, Ann R. ; Wright, Linda L. ; Tyson, Jon E. ; Papile, Lu Ann ; Shankaran, Seetha ; Donovan, Edward F. ; Oh, William ; Bauer, Charles R ; Saha, Shampa ; Poole, W. Kenneth ; Stoll, Barbara. / Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. In: Journal of Pediatrics. 2002 ; Vol. 141, No. 3. pp. 370-375.
@article{5ef799e48cdd442a96f8605130966143,
title = "Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants",
abstract = "Objective: To determine whether minimal ventilation decreases death or bronchopulmonary dysplasia (BPD). Study design: Infants with birth weight 501 g to 1000 g and mechanically ventilated before 12 hours were randomly assigned to minimal ventilation (partial pressure of carbon dioxide [PCO2] target >52 mm Hg) or routine ventilation (PCO2 target <48 mm Hg) and a tapered dexamethasone course or saline placebo for 10 days, using a 2 × 2 factorial design. The primary outcome was death or BPD at 36 weeks' postmenstrual age. Results: After enrollment of 220 patients, the trial was halted because of unanticipated nonrespiratory adverse events related to dexamethasone therapy. The relative risk for death or BPD at 36 weeks in the minimal versus routine ventilation groups was 0.93 (95{\%} CI, 0.77-1.12; P = .43). Ventilator support at 36 weeks was 1{\%} in the minimal versus 16{\%} in the routine group (P < .01). Major morbidities and long-term outcome were comparable in both treatment groups. Conclusions: With the sample size studied, minimal ventilation did not reduce the incidence of death or BPD. The reduced ventilator support at 36 weeks in the minimal ventilation group warrants further study of this intervention.",
author = "Carlo, {Waldemar A.} and Stark, {Ann R.} and Wright, {Linda L.} and Tyson, {Jon E.} and Papile, {Lu Ann} and Seetha Shankaran and Donovan, {Edward F.} and William Oh and Bauer, {Charles R} and Shampa Saha and Poole, {W. Kenneth} and Barbara Stoll",
year = "2002",
month = "9",
day = "1",
doi = "10.1067/mpd.2002.127507",
language = "English",
volume = "141",
pages = "370--375",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants

AU - Carlo, Waldemar A.

AU - Stark, Ann R.

AU - Wright, Linda L.

AU - Tyson, Jon E.

AU - Papile, Lu Ann

AU - Shankaran, Seetha

AU - Donovan, Edward F.

AU - Oh, William

AU - Bauer, Charles R

AU - Saha, Shampa

AU - Poole, W. Kenneth

AU - Stoll, Barbara

PY - 2002/9/1

Y1 - 2002/9/1

N2 - Objective: To determine whether minimal ventilation decreases death or bronchopulmonary dysplasia (BPD). Study design: Infants with birth weight 501 g to 1000 g and mechanically ventilated before 12 hours were randomly assigned to minimal ventilation (partial pressure of carbon dioxide [PCO2] target >52 mm Hg) or routine ventilation (PCO2 target <48 mm Hg) and a tapered dexamethasone course or saline placebo for 10 days, using a 2 × 2 factorial design. The primary outcome was death or BPD at 36 weeks' postmenstrual age. Results: After enrollment of 220 patients, the trial was halted because of unanticipated nonrespiratory adverse events related to dexamethasone therapy. The relative risk for death or BPD at 36 weeks in the minimal versus routine ventilation groups was 0.93 (95% CI, 0.77-1.12; P = .43). Ventilator support at 36 weeks was 1% in the minimal versus 16% in the routine group (P < .01). Major morbidities and long-term outcome were comparable in both treatment groups. Conclusions: With the sample size studied, minimal ventilation did not reduce the incidence of death or BPD. The reduced ventilator support at 36 weeks in the minimal ventilation group warrants further study of this intervention.

AB - Objective: To determine whether minimal ventilation decreases death or bronchopulmonary dysplasia (BPD). Study design: Infants with birth weight 501 g to 1000 g and mechanically ventilated before 12 hours were randomly assigned to minimal ventilation (partial pressure of carbon dioxide [PCO2] target >52 mm Hg) or routine ventilation (PCO2 target <48 mm Hg) and a tapered dexamethasone course or saline placebo for 10 days, using a 2 × 2 factorial design. The primary outcome was death or BPD at 36 weeks' postmenstrual age. Results: After enrollment of 220 patients, the trial was halted because of unanticipated nonrespiratory adverse events related to dexamethasone therapy. The relative risk for death or BPD at 36 weeks in the minimal versus routine ventilation groups was 0.93 (95% CI, 0.77-1.12; P = .43). Ventilator support at 36 weeks was 1% in the minimal versus 16% in the routine group (P < .01). Major morbidities and long-term outcome were comparable in both treatment groups. Conclusions: With the sample size studied, minimal ventilation did not reduce the incidence of death or BPD. The reduced ventilator support at 36 weeks in the minimal ventilation group warrants further study of this intervention.

UR - http://www.scopus.com/inward/record.url?scp=0036735582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036735582&partnerID=8YFLogxK

U2 - 10.1067/mpd.2002.127507

DO - 10.1067/mpd.2002.127507

M3 - Article

C2 - 12219057

AN - SCOPUS:0036735582

VL - 141

SP - 370

EP - 375

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -